XML 18 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows used in operating activities:    
Net loss $ (6,223,165) $ (1,243,485)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 7,853 2,010
Stock-based compensation expense 393,471 $ 95,856
Common stock issued for advisory services 487,500
Noncash interest expense 3,383 $ 56,349
Changes in operating assets and liabilities:    
Prepaid expenses, deposits and other assets (97,058) 15,121
Accounts payable, accrued expenses and accrued liabilities 797,827 135,371
Net cash used in operating activities (4,630,189) (938,778)
Cash flows provided by investing activities:    
Purchases of property and equipment $ (1,994) (2,183)
Maturities of certificates of deposit $ 2,500,000
Cash received in reverse merger transaction $ 8,500,602
Net cash provided by investing activities 8,498,608 $ 2,497,817
Net increase in cash and cash equivalents 3,868,419 1,559,039
Cash and cash equivalents, beginning of period 1,997,192 2,336,519
Cash and cash equivalents, end of period 5,865,611 3,895,558
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of convertible notes and related accrued interest into common stock 711,495 0
Consideration in connection with RestorGenex Corporation merger transaction $ 21,261,000 $ 0